New Online Tool Aids Decisions on Breast Cancer Endocrine Tx New Online Tool Aids Decisions on Breast Cancer Endocrine Tx
A simple online risk tool to help clinicians decide whether women with hormone receptor-positive breast cancer should continue hormone therapy after 5 years has been developed by UK researchers.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Hematology | HIV AIDS | Hormonal Therapy | Hormones | Women